Operating Expenses Cambiamento Data
AbbVie USD 9.71B 96M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amarin USD 58.77M 56.06M 2025-03
AstraZeneca USD 10.95B 1.04B 2025-06
DBV Technologies USD 41.11M 13.74M 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Halozyme Therapeutics USD 123.28M 48K 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
Novartis USD 9.97B 1.02B 2025-06


Amarin Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.